Regeneron Pharmaceuticals' Interest & Investment Income fell 114.92% to -$6.0 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$25.1 million, marking a year-over-year decrease of 249.12%. This contributed to the annual value of -$25.1 million for FY2017, which is 249.12% down from last year.
Regeneron Pharmaceuticals' Interest & Investment Income amounted to -$25.1 million in FY2017, which was down 249.12% from -$7.2 million recorded in FY2016.
Regeneron Pharmaceuticals' 5-year Interest & Investment Income high stood at -$231,000 for FY2013, and its period low was -$37.4 million during FY2014.
For the 3-year period, Regeneron Pharmaceuticals' Interest & Investment Income averaged around -$15.5 million, with its median value being -$14.2 million (2015).
As far as peak fluctuations go, Regeneron Pharmaceuticals' Interest & Investment Income slumped by 16,078.35% in 2014, and later skyrocketed by 61.89% in 2015.
Over the past 5 years, Regeneron Pharmaceuticals' Interest & Investment Income (Yearly) stood at -$231,000 in 2013, then tumbled by 16,078.35% to -$37.4 million in 2014, then soared by 61.89% to -$14.2 million in 2015, then spiked by 49.48% to -$7.2 million in 2016, then slumped by 249.12% to -$25.1 million in 2017.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value